ECTS credits ECTS credits: 3
ECTS Hours Rules/Memories Student's work ECTS: 32 Hours of tutorials: 2 Expository Class: 30 Interactive Classroom: 11 Total: 75
Use languages Spanish, Galician
Type: Ordinary Degree Subject RD 1393/2007 - 822/2021
Departments: Pharmacology, Pharmacy and Pharmaceutical Technology
Areas: Pharmacology
Center Faculty of Medicine and Dentistry
Call: First Semester
Teaching: With teaching
Enrolment: Enrollable
1. To understand drug discovery and development's conceptual and methodological aspects. The student should acquire the ability to analyze the scientific literature related to clinical drug research critically.
2. To develop attitudes and skills, including knowledge of the latest scientific and technological advances, such as Artificial Intelligence, in personalized and precision medicine drug prescription.
3. To enable students to integrate drug-dependent factors, the patient's characteristics, and their socioeconomic environment into the rational use of medications.
Lectures
DRUG EVALUATION
Topic 1. Discovery and development of new drugs. Clinical trials.
PRESCRIPTION
Topic 2. Drug selection criteria. Bioequivalence. Monitoring. Therapeutic adherence. Safety. Pharmacoepidemiology, Pharmacoeconomics.
Topic 3. Personalized and precision medicine I: Physiological factors that determine therapeutic response.
Topic 4. Personalized and precision medicine I: Pathological factors that influence response to medications.
Topic 5. Personalized and precision medicine III: Simulation models based on Artificial Intelligence.
CARDIOVASCULAR DISEASES
Topic 6. Use of medications in cardiovascular disease (I): Hypertension
Topic 7. Use of medications in cardiovascular disease (II): Heart failure
Topic 8. Use of medications in cardiovascular disease (III): Ischemic heart disease
Topic 9. Use of medications in cardiovascular disease (IV): Dyslipidemia
RESPIRATORY SYSTEM DISEASES
Topic 10. Use of medications in respiratory system diseases
IMMUNE DISEASES
Topic 11. Use of medications in immune-mediated diseases
DIGESTIVE SYSTEM DISEASES
Topic 12. Use of medications in digestive diseases
CENTRAL NERVOUS SYSTEM
Topic 13. Use of medications in neurodegenerative diseases
Topic 14. Use of medications in psychiatric disorders
HEMATOLOGY
Topic 15. Anemias.
Topic 16. Blood Coagulation.
PHARMACOLOGICAL MANAGEMENT OF PROCESSES ASSOCIATED WITH AGING.
Topic 17. Menopause and Andropause.
Topic 18. Management of Diabetic Patients.
Topic 19. Osteoarticular Degenerative Processes.
PAIN
Topic 20. Pharmacological Treatment of Pain.
INFECTIOUS DISEASES
Topic 21. Essential Criteria for Anti-Infective Therapy.
SEMINARS:
SEMINAR 1 and 2. Life Support
SEMINAR 3. Adverse Drug Reactions: Assessment of Attributability and Reporting to Pharmacovigilance Systems. Clinical Cases.
SEMINAR 4. Practical Seminar on Clinical Cases of Infectious Diseases.
SEMINAR 5. Drug interactions: resolution of clinical cases using databases and bibliography.
Books
Ritter JM, Flower R, Henderson G, Kong Loke Y, MacEwan D, Robinson E, Fullerton J (eds). Rang & Dale Pharmacology, 10 ed. Elsevier, 2023.
Brunton L, Knollmann BC (eds). Goodman & Gilman's Las bases Farmacológicas de la Terapéutica, 14ª ed. Mc Graw Hill, 2023.
Wecker L, Ingram S (eds). Brody's Human Pharmacology. Mechanism Based Therapeutics, 67th ed. Elsevier Health Sciences Division, 2024.
Stevens CV. Brenner y Stevens. Farmacología básica. 6 ed. Elsevier, 2023.
Zeind CS, Carvalho MG, Cheng JW, Zaiken K, LaPointe T (eds). Applied Therapeutics. The clinical use of drugs, 12th ed. Wolters Kluver, 2023.
Schwinghammer TL, DiPiro JT, Ellingrod VL, DiPiro CV (eds). DiPiro Pharmacotherapy Handbook, 12th ed. McGraw-Hill Medical, 2023.
Web Pages
Spanish Agency for Medicines and Health Products: http://www.agemed.es
European Medicines Agency: http://www.ema.europa.eu
Food and Drug Administration (USA): http://www.fda.gov
NIH Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/
National Institute of Health and Clinical Excellence (UK): http://www.nice.org.uk
Therapeutic guide in primary care: based on the reasoned selection of medications. Spanish Society of Family and Community Medicine: https://www.guiaterapeutica.net
Consensus guidelines in their latest edition: GEMA, GESEPOC, IMS, GALAXIA, Diabetes Care (ADA)
APPS
Aemps CIMA
SEFH Guide to Drug Interactions
Degree competencies to which the subject contributes:
- Understand the fundamentals of action, indications, and efficacy of therapeutic interventions, based on available scientific evidence.
- Indicate the most appropriate therapy for the most prevalent acute and chronic conditions and patients in the terminal phase.
- Know, critically assess, and use clinical and biomedical information sources to obtain, organize, interpret, and communicate scientific and healthcare information.
- Know how to use information and communication technologies in clinical, therapeutic, preventive, and research activities.
Specific competencies of the subject:
- Correctly write medical prescriptions, adapted to each patient's situation and legal requirements.
- Use drugs appropriately.
- Assess the risk/benefit ratio of diagnostic and therapeutic procedures.
- Prevent and identify interactions and adverse effects.
- Pharmacovigilance.
Lectures, interactive seminars, and tutorials
- Lectures: in-person in the classroom.
- Interactive seminars: in-person in the classroom.
Continuous assessment (will account for 30% of the final grade):
- Continuous assessment of knowledge, attendance, and class participation throughout the course (represents 20% of the final grade).
- Seminars (represents 10% of the final grade): Continuous assessment of specific competencies will be conducted through tutoring of student work submitted at the instructor's suggestion. Attendance at all seminars is mandatory to pass the course.
Final exam (will account for 70% of the final grade):
The multiple-choice exam will have four answer options and only one correct answer. For each incorrect answer, 0.33 points will be deducted from the correct answers. A grade of 5 out of 10 or higher on the exam is required to pass the course. Students must earn at least 25% of their grade for each instructor's subject. In the second session, the type of exam and passing score for the subject will be the same as in the first session.
IN-PERSON: 43 hours distributed as follows:
- Lectures: 30
- Interactive seminars: 10
- Tutorials: 2
- Assessment test: 1
STUDENT PERSONAL WORK: 32 hours
- Attendance and participation in all in-person activities related to teaching the subject.
- Regular reading and monitoring of the texts and other materials recommended by the instructors.
- Use of tutorials to resolve any questions the student may have regarding the content taught.
- Finally, students should focus their studies on understanding the concepts taught and their potential application in the medical field, never limiting themselves to simply assimilating the information.
1. Tampering or intentional falsification of attendance control systems will determine the consideration of non-attendance to the activity and must be communicated to the Reitoría for the initiation of disciplinary actions that could correspond.
2. The continuous evaluation score will be saved only for the following academic year, upon request from the student at the beginning of teaching the subject and provided that the requirements that appear in the published teaching guide are met.
Ma Del Pilar Fernandez Rodriguez
- Department
- Pharmacology, Pharmacy and Pharmaceutical Technology
- Area
- Pharmacology
- Phone
- 881812401
- mdelpilar.fernandez [at] usc.es
- Category
- Professor: University Lecturer
Manuel Freire-Garabal Nuñez
Coordinador/a- Department
- Pharmacology, Pharmacy and Pharmaceutical Technology
- Area
- Pharmacology
- Phone
- 881812248
- manuel.freire-garabal [at] usc.es
- Category
- Professor: University Professor
| Monday | |||
|---|---|---|---|
| 10:30-11:30 | Grupo /CLE_01 | Spanish | Aulario-Classroom 3 |
| 11:30-12:30 | Grupo /CLE_03 | Spanish | Aulario-Classroom 4 |
| Tuesday | |||
| 10:30-11:30 | Grupo /CLE_01 | Spanish | Aulario-Classroom 3 |
| 11:30-12:30 | Grupo /CLE_03 | Spanish | Aulario-Classroom 4 |
| Wednesday | |||
| 10:30-11:30 | Grupo /CLE_01 | Spanish | Aulario-Classroom 3 |
| 11:30-12:30 | Grupo /CLE_03 | Spanish | Aulario-Classroom 4 |
| Thursday | |||
| 10:30-11:30 | Grupo /CLE_01 | Spanish | Aulario-Classroom 3 |
| 11:30-12:30 | Grupo /CLE_03 | Spanish | Aulario-Classroom 4 |
| Friday | |||
| 10:30-11:30 | Grupo /CLE_01 | Spanish | Aulario-Classroom 3 |
| 11:30-12:30 | Grupo /CLE_03 | Spanish | Aulario-Classroom 4 |
| 01.23.2026 12:00-14:30 | Grupo /CLE_01 | Aulario-Classroom 1 |
| 01.23.2026 12:00-14:30 | Grupo /CLE_01 | Aulario-Classroom 2 |
| 01.23.2026 12:00-14:30 | Grupo /CLE_01 | Aulario-Classroom 3 |
| 01.23.2026 12:00-14:30 | Grupo /CLE_01 | Aulario-Classroom 4 |
| 01.23.2026 12:00-14:30 | Grupo /CLE_01 | Aulario-Main Hall |
| 06.19.2026 12:30-15:00 | Grupo /CLE_01 | Aulario-Classroom 1 |
| 06.19.2026 12:30-15:00 | Grupo /CLE_01 | Aulario-Classroom 2 |
| 06.19.2026 12:30-15:00 | Grupo /CLE_01 | Aulario-Classroom 3 |
| 06.19.2026 12:30-15:00 | Grupo /CLE_01 | Aulario-Classroom 4 |
| 06.19.2026 12:30-15:00 | Grupo /CLE_01 | Aulario-Main Hall |